KALYONCU, U. Et Al. 2021. Preferences of inflammatory arthritis patients for biological disease-modifying antirheumatic drugs in the first 100 days of the covid-19 pandemic. Turkish Journal of Medical Sciences , vol.51, no.4 , 1615-1623.

KALYONCU, U., PEHLİVAN, Y., Akar, S., KAŞİFOĞLU, T., Kimyon, G., KARADAĞ, Ö., ... DALKILIÇ, H. E.(2021). Preferences of inflammatory arthritis patients for biological disease-modifying antirheumatic drugs in the first 100 days of the covid-19 pandemic. Turkish Journal of Medical Sciences , vol.51, no.4, 1615-1623.

KALYONCU, UMUT Et Al. "Preferences of inflammatory arthritis patients for biological disease-modifying antirheumatic drugs in the first 100 days of the covid-19 pandemic," Turkish Journal of Medical Sciences , vol.51, no.4, 1615-1623, 2021

KALYONCU, UMUT Et Al. "Preferences of inflammatory arthritis patients for biological disease-modifying antirheumatic drugs in the first 100 days of the covid-19 pandemic." Turkish Journal of Medical Sciences , vol.51, no.4, pp.1615-1623, 2021

KALYONCU, U. Et Al. (2021) . "Preferences of inflammatory arthritis patients for biological disease-modifying antirheumatic drugs in the first 100 days of the covid-19 pandemic." Turkish Journal of Medical Sciences , vol.51, no.4, pp.1615-1623.

@article{article, author={UMUT KALYONCU Et Al. }, title={Preferences of inflammatory arthritis patients for biological disease-modifying antirheumatic drugs in the first 100 days of the covid-19 pandemic}, journal={Turkish Journal of Medical Sciences}, year=2021, pages={1615-1623} }